Leadgene Biomedical
Leadgene Biomedical is a Taiwan-based biotechnology company founded in 2013 that develops recombinant proteins, antibodies, and IVD raw materials — including the world's first Indoxyl Sulfate ELISA Kit for early CKD diagnosis — serving IVD manufacturers, pharma/biotech firms, academic researchers, and nephrology healthcare providers via catalog e-commerce and distributor partnerships.
- Company typePrivate
- Founded2013
- HeadquartersTainan, Taiwan
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Leadgene Biomedical does
Leadgene Biomedical is a privately held Taiwan-based biotechnology company founded in 2013 and headquartered in Tainan, focused on in-vitro diagnostic (IVD) raw materials, recombinant proteins, and antibodies. The company operates twelve product categories — including GMP-grade proteins (LeadGMP®), IVD raw materials, protein engineering tools, molecular biology reagents, enzymes, primary and secondary antibodies, recombinant proteins, cell biology reagents, ELISA kits, rapid test products, and buffers — alongside six service lines covering custom synthesis, protein and antibody development (including VHH/nanobody), development and manufacture, cell line development, and animal model analysis. Its technical platform centers on a proprietary protein expression technique and the world's first Indoxyl Sulfate (IS) ELISA Kit for early chronic kidney disease diagnosis.
The business generates revenue through one-time catalog sales of research-use and GMP-grade reagents via a direct e-commerce storefront, complemented by international distributor partnerships (notably Lab Talent/Palm Science in Vietnam and a Japan market entry via the JSUT conference). Primary customer segments are IVD manufacturers, pharmaceutical and biotechnology companies, academic and research institutions, and healthcare providers focused on CKD management. Pricing is unit-based with customizable package sizes, and pricing is not publicly disclosed.
The company is executing a multi-vector expansion strategy in 2026: it established an AI-based instrumentation distribution division through subsidiary Leadgene Biosolutions (DeepSense Biotech partnership), launched community pharmacy operations via Leadgene Health Business (Trustwell Pharmacy in Tainan), and pursued CKD-care commercialization in partnership with Standard Biotechnology & Pharmaceutical at the Taiwan Society of Nephrology conference. The firm is led by co-founder/CEO Louis Yu-Wei Cheng and Chairman/CTO Chasel Yung-Chun Chuang, with Darwin Venture Management identified as a 2023 investor.
Leadgene Biomedical firmographics
Firmographics- Name
- Leadgene Biomedical
- Legal name
- Leadgene Biomedical, Inc.
- Website
- https://leadgenebio.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Leadgene Biomedical is a Taiwan-based biotechnology company founded in 2013 that develops recombinant proteins, antibodies, and IVD raw materials — including the world's first Indoxyl Sulfate ELISA Kit for early CKD diagnosis — serving IVD manufacturers, pharma/biotech firms, academic researchers, and nephrology healthcare providers via catalog e-commerce and distributor partnerships.
- Ownership category
- akta.pro rank
Leadgene Biomedical industry classification
Industry- Product category
- Biotechnology reagents and IVD raw materials
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)
- akta.pro secondary industry
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where Leadgene Biomedical is headquartered
LocationHeadquarters
- HQ city
- Tainan
- HQ country
- Taiwan
- HQ region
- Asia
Offices1 record
Markets served
Leadgene Biomedical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Research Reagents and Proteins: Sale of recombinant proteins, cytokines, growth factors, enzymes, and cell biology reagents for research applications. Products are offered in various grades including RUO (Research Use Only) and GMP-grade.
- Antibody Products: Sale of primary and secondary antibodies for IVD, ELISA, Western blotting, and other immunoassays. Includes monoclonal, recombinant, and biosimilar antibodies.
- IVD Raw Materials: Supply of components for in-vitro diagnostic product manufacturing including antibodies, enzymes, and buffers used in diagnostic test kits.
- Custom Synthesis Services: Custom protein development services covering gene synthesis, cloning, expression, purification, labeling, activity testing, and format optimization. Also includes VHH/nanobody development services.
- ELISA and Diagnostic Kits: Sale of ELISA kits including the Indoxyl Sulfate (IS) ELISA Kit for CKD diagnosis and rapid test products for various pathogens.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Catalog products with customizable package sizes |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Leadgene Biomedical product offering
Product offeringCore offering
Leadgene Biomedical manufactures and sells in-vitro diagnostic raw materials, recombinant proteins, and antibodies for global life sciences customers through a catalog of 12 product categories. Its offerings include GMP-grade proteins, ELISA kits (notably the world-first Indoxyl Sulfate ELISA Kit for CKD), molecular biology reagents, cell biology reagents, rapid test kits, and buffers, complemented by custom synthesis, protein, antibody, and contract development and manufacturing services.
Product overview
Leadgene Biomedical is a biomedical company specializing in protein and antibody reagent innovation and production. The company operates a multi-product portfolio organized into 12 product categories: GMP-Grade Products (LeadGMP®) for pharmaceutical and cell therapy applications; IVD Products for in-vitro diagnostic raw materials; Protein Engineering tools (conjugation kits, purification kits, agarose beads); Molecular Biology reagents (PCR/RT-PCR, CRISPR/Cas9); Enzymes (proteases, glycosidases, dehydrogenases); Primary Antibodies (monoclonal, recombinant, biosimilar); Secondary Antibodies (HRP, fluorescent conjugates); Recombinant Proteins (cytokines, growth factors, viral antigens); Cell Biology Reagents (transfection reagents, 3D culture hydrogels); ELISA Kits (including the world-first Indoxyl Sulfate IS ELISA Kit for CKD); Rapid Test Products (lateral flow assays); and Buffers. Additionally, Leadgene offers six service lines: Synthesis, Protein, Antibody (including VHH/nanobody development), Development & Manufacture, Cell Line Development, and Animal Model Analysis services. The company also operates Leadgene Health Business for community health services including Trustwell Pharmacy. Key research focus areas include Chronic Kidney Disease (CKD), Nipah Virus, COVID-19, Cancer, Cardiovascular disease, and various infectious diseases (Dengue, Influenza, Hepatitis B, Zika).
Differentiator
Problem solved
Functional benefit
Brands
- Leadgene Group: Parent group bridging tools to clinical evidence, accelerating customer success.
- LeadGMP
- HyLink
- LEADSPHERE
- EffiStart
- VHH Development
- LEADGENE GROUP
Products and services
- GMP-Grade Products (LeadGMP®) GMP-grade proteins produced under good manufacturing practices for pharmaceuticals, medical devices, and cell therapy components, available through the LeadGMP product line.
- IVD Products In-vitro diagnostic raw materials including antibodies, enzymes, and buffers for medical diagnostic test development and manufacturing.
- Protein Engineering Tools (including HyLink) Premium protein engineering tools including protein labeling and conjugation kits, purification kits, and agarose beads for research and development workflows.
- Molecular Biology Reagents (LEADSPHERE and EffiStart) High-quality PCR and RT-PCR reagents and master mixes for DNA amplification, in vitro transcription, and CRISPR/Cas9 applications in gene cloning, expression analysis, and diagnostics.
- Enzymes Molecular and industrial enzymes including proteases, glycosidases, dehydrogenases, and oxidoreductases for research and diagnostic applications.
- Primary Antibodies Monoclonal, recombinant, and biosimilar primary antibodies for IVD and disease diagnostics, targeting markers such as Nipah, SARS-CoV-2, Dengue, Zika, and Influenza antigens.
- Secondary Antibodies Secondary antibodies conjugated with HRP, TAMRA, FAM, and iFluor dyes for ELISA, Western blotting, immunohistochemistry, and lateral-flow assays.
- Recombinant Proteins RUO-grade recombinant proteins including cytokines, growth factors, chemokines, viral antigens, neurotrophins, lectins, and CD antigens expressed in E. coli, HEK293, CHO, and Pichia pastoris systems.
- Cell Biology Reagents Cell biology reagents including HyFect® transfection reagents, 3D cell culture hydrogels (ScaffoldForm, XenoForm Tumor Gel), and apoptosis detection reagents for cell-based research.
- ELISA Kits Comprehensive catalog of ELISA kits for detecting specific molecules in biological samples, including the Indoxyl Sulfate (IS) ELISA Kit, SARS-CoV-2, DENV NS1, MMP7, HDGF, and RAGE kits.
- Rapid Test Products Lateral flow rapid test kits for antigen detection including Nipah Virus, Gliadin allergen, and Human Metapneumovirus for Research Use Only.
- Buffers (LG-1, LG-2, LG-3, LG-4 2X Diluent Buffers) LG-1, LG-2, LG-3, and LG-4 2X Diluent Buffers formulated to optimize immunoassay workflows by reducing matrix effects and non-specific binding.
- Leadgene® Indoxyl Sulfate (IS) ELISA Kit World-first ELISA kit for detection of Indoxyl Sulfate, a protein-bound uremic toxin, enabling earlier chronic kidney disease diagnosis and disease management while simplifying previously complex testing workflows.
- Synthesis Service Custom synthesis services for nucleic acids and other biomolecules, offered as a contracted service to research and industry customers.
- Protein Service Custom protein development services covering gene synthesis, cloning, expression, purification, labeling, activity testing, and format optimization.
- Antibody Service Custom antibody development services, including VHH/nanobody development, tailored to customer-defined specifications.
- VHH/nanobody Development Service Custom VHH (nanobody) development service where customers select targets from the catalog and receive tailored VHH antibodies.
- Development & Manufacture Service Contract development and manufacturing services for biomolecules.
- Cell Line Development Service Custom cell line development services for protein production.
- Animal Model Analysis Service Animal model analysis services for preclinical research.
Companies that use Leadgene Biomedical
Customer profileSegments4 records
Ideal customer profiles4 records
Leadgene Biomedical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Leadgene Biomedical partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- DeepSense BiotechcoreLeadgene Biomedical's subsidiary, Leadgene Biosolutions, entered into a strategic partnership with DeepSense Biotech to establish a new AI-based instrumentation distribution business division. This partnership expands Leadgene's capabilities into AI-based instrumentation distribution.
- Lab Talent (Palm Science)coreStrategic partnership with Lab Talent (Palm Science), a leading Vietnam-based provider of laboratory solutions, to serve as the official distributor for Leadgene Biomedical products in Vietnam.
- Standard Biotechnology & PharmaceuticalcoreLeadgene Biomedical and Standard Biotechnology & Pharmaceutical showcased their chronic kidney disease (CKD) diagnostic and care solutions at the Spring Academic Conference of the Taiwan Society of Nephrology (TSN), demonstrating gut-kidney axis care solutions.
Scale indicators1 record
Recent moves6 records
Expansion highlights6 records
Leadgene Biomedical competitors and assessment
Company assessmentDirect peers
- GenScript: GenScript is a direct peer offering recombinant proteins, antibodies, gene synthesis, and IVD raw materials globally — overlapping heavily with Leadgene's catalog across custom protein services, antibody development, and research reagents.
- Sino Biological: Sino Biological is a direct peer specializing in recombinant proteins, antibodies, and ELISA kits for research and IVD applications, with comparable catalog breadth across cytokines, viral antigens, and diagnostic raw materials.
- ACROBiosystems: ACROBiosystems is a direct peer focused on recombinant proteins, GMP-grade biologics, and IVD raw materials, closely mirroring Leadgene's combination of research-use proteins and GMP-grade products for cell therapy and pharma.
- Medix Biochemica: Medix Biochemica is a direct peer specializing in IVD raw materials — antibodies, antigens, and diagnostic reagents — closely aligned with Leadgene's IVD Products line and ELISA/rapid test kit businesses.
- Cell Signaling Technology: Cell Signaling Technology is a direct peer producing high-quality primary antibodies, ELISA kits, and reagents for signaling pathways and disease research, with overlapping product positioning in Western blot and disease-focused research reagents.
- Proteintech: Proteintech is a direct peer focused on antibodies and recombinant proteins for academic and industrial life science research, with comparable catalog scope across primary antibodies and ELISA-grade proteins.
Broad incumbents
- Bio-Techne: Bio-Techne (including R&D Systems, Novus Biologicals, Tocris, ProteinSimple) is a broad incumbent across recombinant proteins, antibodies, ELISA kits, and GMP reagents — competing with Leadgene across most product categories at much larger scale.
- Abcam: Abcam (now part of Danaher) is a broad incumbent in primary and secondary antibodies used in research and IVD, comparable to Leadgene's antibody catalog and overlapping in ELISA, Western blot, and IHC applications.
- PeproTech (Thermo Fisher): PeproTech, now part of Thermo Fisher Scientific, is a broad incumbent in recombinant cytokines and growth factors for cell therapy and GMP applications — directly comparable to Leadgene's recombinant protein and LeadGMP lines.
Regional players
- Arigo Biolaboratories: Arigo Biolaboratories is a Taiwan-based regional player offering antibodies, proteins, ELISA kits, and IVD reagents, comparable to Leadgene in product mix and Asia-Pacific geographic footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Leadgene Biomedical social profiles
Digital presenceLeadgene Biomedical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Leadgene Biomedical leadership team
Management profileNumber of profiles
Profiles2 records
Leadgene Biomedical subsidiaries and ownership
Company hierarchySubsidiaries2 records
Leadgene Biomedical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Leadgene Biomedical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Leadgene Biomedical
What does Leadgene Biomedical do?
Leadgene Biomedical manufactures and sells in-vitro diagnostic raw materials, recombinant proteins, and antibodies for global life sciences customers through a catalog of 12 product categories. Its offerings include GMP-grade proteins, ELISA kits (notably the world-first Indoxyl Sulfate ELISA Kit for CKD), molecular biology reagents, cell biology reagents, rapid test kits, and buffers, complemented by custom synthesis, protein, antibody, and contract development and manufacturing services.
Is Leadgene Biomedical a public or private company?
Leadgene Biomedical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Leadgene Biomedical founded?
Leadgene Biomedical was founded in 2013. It employs 51 to 100 people.
Where is Leadgene Biomedical based?
Leadgene Biomedical is headquartered in Tainan, Taiwan, in the Asia region.
How does Leadgene Biomedical make money?
Five revenue lines are on record. Research Reagents and Proteins are the primary driver. The others are antibody Products, IVD Raw Materials, custom Synthesis Services and ELISA and Diagnostic Kits.
Who are Leadgene Biomedical's main competitors?
Direct peers on record are GenScript, Sino Biological, ACROBiosystems, Medix Biochemica, Cell Signaling Technology and Proteintech. Broad incumbents are Bio-Techne, Abcam and PeproTech (Thermo Fisher). Arigo Biolaboratories is listed as a regional player.
Does Leadgene Biomedical have an API?
No public API is recorded for Leadgene Biomedical.
What industry is Leadgene Biomedical in?
Leadgene Biomedical's product category is Biotechnology reagents and IVD raw materials. Its primary akta.pro industry code is HLAGAGAI, Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines), with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 325414 and its SIC code is 2836.